Exploration if Saizen marketed solution for injection induces an immunogenic reaction

Update Il y a 4 ans
Reference: EUCTR2012-004263-47

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine whether the marketed Saizen solution for injection, administered according to the approved label for 9 months (39 weeks) in adults with GHD, induces the development of binding antibodies (BAbs).


Inclusion criteria

  • Adult Growth Hormone Deficiency